Abstract
Background
The prognosis for gastric cancer patients with distant metastasis is very poor. The purpose of this study was to evaluate the survival benefit of non-curative gastrectomy for gastric cancer patients with synchronous distant metastasis.
Methods
From 1992 to 2002, 253 gastric cancer patients with synchronous distant metastasis underwent surgery at the Department of Surgery, Ruijin Hospital, China. The clinicopathological characteristics and survival were compared between resection and non-resection groups.
Results
The 5-year survival rate was 6.5% for patients in resection group and 0% for patients in non-resection group (P < 0.001). Multivariate analysis showed that liver metastasis, peritoneal dissemination, and non-resection were significantly associated with poor prognosis in gastric cancer patients with distant metastasis. The survival difference between resection and non-resection groups was only observed in patients with single peritoneal dissemination (P < 0.001), but were not in patients with single liver metastasis (P = 0.428), distant nodes involvement (P = 0.490) and multiple metastatic sites (P = 0.192), respectively.
Conclusions
Our results suggests that there were no survival benefit from non-curative gastrectomy for patients with single liver, distant nodes, or multiple sites metastasis. However, only patients with single peritoneal dissemination had survival benefit from non-curative resection. The value of non-curative resection should be evaluated by well-designed clinical trials.
Similar content being viewed by others
References
Jemal A, Tiwari RC, Murray T et al. Cancer statistics 2004. CA Cancer J Clin 2004;54:8–29.
Yang L. Incidence and mortality of gastric cancer in China. World J Gastroenterol. 2006;12(1):17–20.
Yang L, Parkin DM, Ferlay J et al. Estimates of cancer incidence in China for 2000 and projections for 2005. Cancer Epidemiol Biomarkers Prev 2005;14:243–250.
Hansson LE, Sparen P, Nyren O. Survival in stomach cancer is improving: results of a nationwide population-based Swedish study. Ann Surg 1999;230(2):162–169.
Sano T, Katai H, Sasako M, Maruyama K. The management of early gastric cancer. Surg Oncol 2000;9(1):17–22.
Yagi Y, Seshimo A, Kameoka S. Prognostic factors in stage IV gastric cancer: univariate and multivariate analyses. Gastric Cancer 2000;3:71–80.
Monson JR, Donohue JH, McIlrath DC et al. Total gastrectomy for advanced cancer. A worthwhile non-curative procedure. Cancer 1991;68:1863–1868.
McCarter MD, Fong Y. Role for surgical cytoreduction in multimodality treatments for cancer. Ann Surg Oncol 2001;8:38–43.
Saidi RF, ReMine SG, Dudrick PS et al. Is there a role for non-curative gastrectomy in patients with stage IV gastric cancer? World J Surg 2006;30:21–27.
Hartgrink HH, Putter H, Klein Kranenbarg E et al. Value of non-curative resection in gastric cancer. Br J Surg 2002;89:1438–1443.
Sobin LH, Wittekind C. International Union against Cancer TNM classification of malignant tumours. 5th ed. New York: Wiley-Liss, 1997.
Nakajima T. Gastric cancer treatment guidelines in Japan. Gastric Cancer 2002;5:1–5.
Fujisaki S, Tomita R, Nezu T et al. Prognostic studies on gastric cancer with concomitant liver metastases. Hepatogastroenterology 2001;48:892–894.
Li C, Yan M, Chen J et al. Prognostic influence of sub-stage according to pTNM category in patients with stage IV gastric cancer. J Surg Oncol 2009;99:324–328.
Takeno S, Noguchi T, Kikuchi R et al. Analysis of the survival period in resectable stage IV gastric cancer. Ann Surg Oncol 2001;8(3):215–221.
Pollock RE, Roth JA. Cancer-induced immunosuppression: implication for therapy? Semin Surg Oncol 1989;5:414–419.
Park SH, Kim JH, Park JM et al. Value of nonpallative resection as a therapeutic and pre-emptive operation for metastatic gastric cancer. World J Surg 2009;33:303–311.
Samarasam IB, Chandran BS, Sitaram V et al. Non-curative gastrectomy in advanced gastric cancer: is it worthwhile? ANZ J Surg 2006;76:60–63.
Zhu ZG, Tang R, Yan M et al. Efficacy and safety of intraoperative peritoneal hyperthermic chemotherapy for advanced gastric cancer patients with serosal invasion. A long-term follow-up study. Digestive Surgery 2006;23:93–102.
Sasako M, Sano T, Yamamoto S et al. D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N Engl J Med 2008;359(5):453–462.
Yonemura Y, Wu CC, Fukushima N et al. Operative morbidity and mortality after D2 and D4 extended dissection for advanced gastric cancer: a prospective randomized trial conducted by Asian surgeons. Hepatogastroenterology 2006;53:389–394.
Orditura M, Martinelli E, Galizia G et al. Chemoradiotherapy as adjuvant treatment of gastric cancer. Ann Oncol 2007;18(Suppl 6):133–135.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Li, C., Yan, M., Chen, J. et al. Survival Benefit of Non-curative Gastrectomy for Gastric Cancer Patients with Synchronous Distant Metastasis. J Gastrointest Surg 14, 282–288 (2010). https://doi.org/10.1007/s11605-009-1095-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11605-009-1095-0